PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
May 1, 2008, 00:00
10.1016/S1098-3015(10)70236-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)70236-9/fulltext
Title :
PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70236-9&doi=10.1016/S1098-3015(10)70236-9
First page :
Section Title :
Open access? :
No
Section Order :
888